Study Advances Cancer Precision Therapies by Identifying Patients Who Benefit From Bexmarilimab Treatment

Supercharged Antibodies: Scientists Engineer Potent New Weapon Against Cancer

Scientists have created a new type of super-strong antibody that could significantly enhance cancer immunotherapy. In an exciting advance for cancer treatment, scientists have developed a new type of powerful antibody that could help the immune system fight cancer more effectively. Researchers at the University of Southampton have redesigned antibodies, tiny proteins produced by white [...]

Study advances cancer precision therapies by identifying patients who benefit from bexmarilimab treatment

Researchers at the University of Turku, Finland, have taken a step towards more personalized and effective cancer treatments. A new study has identified the conditions under which the antibody drug bexmarilimab can activate the body's own defense system against cancer, and how to identify patients who will benefit from the drug.

Researchers at the University of Turku have taken a step towards more personalized and effective cancer treatments, the university said in a press release. The new study revealed under what conditions the antibody drug bexmarilimab can activate the body's own defense system against cancer and how to identify patients who would benefit from the drug.

New study advances cancer precision therapies by identifying patients who benefit from Bexmarilimab treatment

Researchers at the University of Turku, Finland, have taken a step towards more personalised and effective cancer treatments. A new study has identified the conditions under which the antibody drug bexmarilimab can activate the body's own defence system against cancer, and how to identify patients who will benefit from the drug. The study was published in the Journal for ImmunoTherapy of Cancer.